Prostaglandins and Immunity

  • M. A. Bray
  • J. Morley
Part of the NATO Advanced Study Institutes Series book series


Immune mechanisms fall into two major classes: firstly, reactions of humoral immunity involving the generation of antibodies by bone marrow derived thymus independent lymphocytes (B-lymphocytes); secondly, reactions of cellular immunity involving the generation of lymphokines, by thymus dependent lymphocytes (T-lymphocytes). Lymphokines are macromolecular agents, probably glycoprotein, which affect a range of cell types, including macrophages, neutrophils, lymphocytes, osteoclasts and vascular endothelium. Within this general framework there exists a range of cell/cell interactions to both specific antigens and nonspecific stimuli of lymphocyte function leading to the generation of antibodies or lymphokines. As well as mediator release in response to antigen stimulus T-lymphocytes are involved in the control of antibody secretion. Macrophages also play a role in the allergic response serving to regulate the secretion of lymphokines or antibodies. Neutrophils, eosinophils and basophils are more usually considered to be involved in immediate hypersensitivity anaphylactic type reactions though involvement in other responses may be more than incidental (e.g. basophils in Jones-Mote responses).


Antibody Secretion Lipoxygenase Product Cyclic Nucleotide Level Macrophage Migration Inhibition Graft Versus Host 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    C. B. Anderson, W. T. Newton and B. M. Jaffe. Transplantation, 19: 527 (1975).PubMedCrossRefGoogle Scholar
  2. 2.
    M. A. Bray, D. Gordon and J. Morley. Agents and Actions, 6: 171 (1976).CrossRefGoogle Scholar
  3. 3.
    M. A. Bray, D. Gordon and J. Morley. Prostaglandins and Med., 1: 183 (1978).CrossRefGoogle Scholar
  4. 4.
    M. A. Bray and J. Morley. In: “Immunology in Medicine” E. Holborow and W. G. Reeves, eds., Academic Press, London, 265 (1977).Google Scholar
  5. 5.
    K. Brune, M. Glatt, H. Kalin and B. A. Peskar. Nature, 274: 261 (1978).PubMedCrossRefGoogle Scholar
  6. 6.
    J. Calderon and E. R. Unanue. Nature, 253: 359 (1975).PubMedCrossRefGoogle Scholar
  7. 7.
    J. F. Dayer, S. R. Goldring and S. M. Krane. In: “Proc. Mech. Localised Bone Loss”, J. E. Horton, T. M. Tarpley and W. F. Davis, eds., Inf. Res. Inc. U.S.A., 181 (1978).Google Scholar
  8. 8.
    M. DuComb, P. Polgar and C. Franzblau. Prostaglandins, 15: 708 (1978).Google Scholar
  9. 9.
    A. Farzad, A. S. Penneys, A. Ghaffar, V. A. Ziboh and J. Schlossberg. Prostaglandins, 14: 829 (1979).Google Scholar
  10. 10.
    E. J. Goetzl, J. A. Wood and R. R. Gorman. J. Clin.Invest., 59: 179 (1977).PubMedCrossRefGoogle Scholar
  11. 11.
    J. S. Goodwin, A. D. Bankhurst, S. A. Murphy, D. S. Selinger, R. P. Messner and R. C. Williams. J. Clin. Lab. Immunol., 1: 197 (1978).Google Scholar
  12. 12.
    J. S. Goodwin, R. P. Messner, A. D. Bankhurst, G. T. Peake, J. H. Saiki and R. C. Williams. New Eng. J. Med., 297: 963 (1977).PubMedCrossRefGoogle Scholar
  13. 13.
    T. J. Hubscher. J. Immunol., 114: 1389 (1975).PubMedGoogle Scholar
  14. 14.
    J. L. Humes, R. J. Bonney, L. Pelus, M. E. Dahlgren,S.J. Vsadowski, F. A. Keuhl and P. Davies. Nature, 269: 149 (1977).PubMedCrossRefGoogle Scholar
  15. 15.
    J. L. Humes and H. R. Strausser. Prostaglandins, 5: 183 (1974).PubMedGoogle Scholar
  16. 16.
    J. P. Kelly, M. C. Johnson and C. W. Parker. J. Immunol., 122: 1563 (1979).PubMedGoogle Scholar
  17. 17.
    P. J. Kirby, J. Morley, J. R. Ponsford and W. I. McDonald. Prostaglandins, 11: 621 (1976).PubMedGoogle Scholar
  18. 18.
    T. Kishimoto and K. Ishizaka. J. Immunol., 116: 534 (1976).PubMedGoogle Scholar
  19. 19.
    E. A. Kitchen, J. R. Boot and W. Dawson. Prostaglandins, 16: 239 (1978).PubMedGoogle Scholar
  20. 20.
    F. A. Kuehl. Comprehensive Immunology, 3: 145 (1977).Google Scholar
  21. 21.
    J. I. Kurland, R. S. Bockman, H. E. Broxmeyer and M. A. Moore. Science, 199: 552 (1978).PubMedCrossRefGoogle Scholar
  22. 22.
    L. M. Lichtenstein, E. Gillespie, H. R. Bourne and C. S. Henney. Prostaglandins, 2: 519 (1972).PubMedGoogle Scholar
  23. 23.
    L. M. Lichtenstein and S.Margolis. Science, 161: 902 (1968).CrossRefGoogle Scholar
  24. 24.
    L. D. Loose and N. R. Di Luzio. J. Retic. Soc., 13: 70 (1973).Google Scholar
  25. 25.
    J. Mendelsohn, M. M. Multer and R. F. Boone. J. Clin. Invest., 52: 2129 (1973).CrossRefGoogle Scholar
  26. 26.
    J. Mertin and D. Hughes. Int. Arch. Allergy Appl. Immunol., 48: 203 (1975).CrossRefGoogle Scholar
  27. 27.
    J. Morley. Prostaglandins, 8: 315 (1974).PubMedGoogle Scholar
  28. 28.
    J. Morley. In: “Inflammation” (eds. J. R. Vane and S. H. Ferreira, Handbook of Exp. Pharm., 50/1. 314 (178).Google Scholar
  29. 29.
    J. Morley, M. A. Bray, R. W. Jones, D. H. Nugteren and D. A. Van Dorp. Prostaglandins, 17: 730 (1979).Google Scholar
  30. 30.
    L. Myatt, M. A. Bray, D. Gordon and J. Morley. Nature, 257: 227 (1975).PubMedCrossRefGoogle Scholar
  31. 31.
    C. W. Parker, J. P. Kelly, S. F. Falkenheim and M. G. Huber. J. Exp. Med., 149: 1487 (1979).PubMedCrossRefGoogle Scholar
  32. 32.
    C. W. Parker, W. F. Stenson, M. G. Huber and J. P. Kelly. J. Immunol., 122: 1572 (1979).PubMedGoogle Scholar
  33. 33.
    L. M. Pelus, H. E. Broxmeyer, J. I. Kurland and M. A. Moore. J. Exp. Med., 150: 277 (1979).PubMedCrossRefGoogle Scholar
  34. 34.
    L. M. Pelus and H. R. Strausser. Life Sciences, 20: 903 (1977).PubMedCrossRefGoogle Scholar
  35. 35.
    L. M. Pelus and H. R. Strausser. Int. J. Cancer, 18: in press.Google Scholar
  36. 36.
    J. Plescia, A. Smith and K. Grinwich. Proc. Nat. Acad. Sci. U.S.A., 72: 1848 (1975).CrossRefGoogle Scholar
  37. 37.
    F. Quagliata, V. S. W. Lawrence and J. M. PhilipsQuagliata. Cell. Immunol., 6: 457 (1973).PubMedCrossRefGoogle Scholar
  38. 38.
    I. Rivkin and E. L. Becker. Fed. Proc., 31: 657 (1972).Google Scholar
  39. 39.
    I. Rivkin, J. Rosenblatt and E. L. Becker. J. Immunol., 115: 1126 (1975).PubMedGoogle Scholar
  40. 40.
    J. W. Smith, A. L. Steiner and C. W. Parker. J. Clin. Invest., 50: 442 (1971).Google Scholar
  41. 41.
    G. D. Stockman and D. M. Mumford. Exp. Haematol., 2: 65 (1974).Google Scholar
  42. 42.
    K. F. Trofatter and C. A. Daniels. J. Immunol., 122: 1363 (1979).PubMedGoogle Scholar
  43. 43.
    F. H. Valone, M. Franklin and E. J. Goetzl. Clin. Res., 27: 476A (1979).Google Scholar
  44. 44.
    D. R. Webb and P. L. Osheroff. Proc. Nat. Acad. Sci. U.S.A., 73: 1300 (1976).CrossRefGoogle Scholar
  45. 45.
    G. Weissmann,P. Dukor and R. B. Zurier. Nature (New Biol.), 231: 131 (1971).Google Scholar
  46. 46.
    G. Weissmann,R. B. Zurier and S. Hoffstein. Am. J. Pathol., 68: 539 (1972).Google Scholar
  47. 47.
    T. Yoneda and G. R. Mundy. J. Exp. Med., 150: 338 (1979).PubMedCrossRefGoogle Scholar
  48. 48.
    M. Zimecki and D. R. Webb. J. Immunol., 117: 2158 (1976).PubMedGoogle Scholar
  49. 49.
    R. B. Zurier and F. Quagliata. Nature, 234: 304 (1971).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • M. A. Bray
    • 1
  • J. Morley
    • 1
  1. 1.Clinical PharmacologyCardio-throacic InstituteLondonUK

Personalised recommendations